drugset / Trial / NCT00110708
Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine if human immunoglobulin given by mouth twice a day is effective in treating the persistent gastrointestinal (GI) problems such as diarrhea, constipation, abdominal pain, and bloating, in children with autism.
Timeline
- Start
- 2005-04
- Primary completion
- —
- Completion
- 2006-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oralgam | Protein / enzyme biologic | 140 mg | Oral |
| Subject | Oralgam | Protein / enzyme biologic | 420 mg | Oral |
| Subject | Oralgam | Protein / enzyme biologic | 840 mg | Oral |